BB-102(Benitec Biopharma)

N/A

Report date: 2022/08/15 13:58:32
NME

Base Information

Drug NameBB-102(Benitec Biopharma)
Drug Alias NameBB-102(Benitec Biopharma)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitorsRNA interference
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBenitec Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBenitec Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A